Comparability of portable and desktop spirometry: a randomized, parallel assignment, open-label clinical trial

被引:9
|
作者
Boros, Piotr W. [1 ]
Maciejewski, Adrian [2 ]
Nowicki, Michal Maciej [3 ]
Wesolowski, Stefan [1 ]
机构
[1] Inst TB & Lung Dis, Lung Pathophysiol Dept, Ul Plocka 26, PL-01138 Warsaw, Poland
[2] Poznan Univ Med Sci, Dept Rescue Med, Poznan, Poland
[3] Inst Cardiol, Dept Intens Cardiac Therapy, Warsaw, Poland
关键词
spirometry; asthma; chronic obstructive pulmonary disease; ASTHMA; STANDARDIZATION; EXACERBATIONS; TELEMEDICINE; COPD;
D O I
10.5603/ARM.a2022.0013
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction: Portable spirometers are often perceived as inaccurate. We aimed to evaluate the performance of AioCare (R), a new portable spirometer, by comparing it with a reference desktop spirometer. Materials and methods: Sixty-two patients diagnosed with asthma or chronic obstructive pulmonary disease performed spirometry examinations on a portable and the reference spirometer. The patients were randomized to two groups with different order, in which the spirometers were used. Forced expiratory volume in one second (FEV1), forced vital capacity (FVC), peak expiratory flow (PEF) and FEV1/FVC rate were compared. Results: The study revealed a high correlation in FEV1, FVC, FEV1/FVC and PEF between portable and reference spirometers. The mean differences between measurements obtained from the AioCare (R) and reference spirometer were: 0.0079 liter for FEV1 (p = 0.61), 0.05 liter for FVC (p = 0.14), 5.1 liter/min for PEF (p = 0.28) and -0.0034 for FEV1/FVC rate (p = 0.54). Pearson correlation coefficient analysis showed high association of FEV1 (R = 0.994; 95% CI: 0.990-0.997; p < 0.001), FVC (R = 0.984; 95% CI: 0.974-0.990; p < 0.001), PEF (R = 0.965; 95% CI: 0.942-0.979; p < 0.001), and FEV1/FVC (R = 0.954; 95% CI: 0.924-0.972; p < 0.001) readings from both spirometers. Conclusions: Our results indicate that the portable spirometer produces largely similar readings to those obtained by a stationary spirometer in patients with chronic lung diseases, and therefore it may serve as a complementary tool in daily, remote management of patients with lung diseases.
引用
收藏
页码:60 / 67
页数:8
相关论文
共 50 条
  • [1] Portable hypothermic oxygenated machine perfusion for organ preservation in liver transplantation: A randomized, open-label, clinical trial
    Panayotova, Guergana G.
    Lunsford, Keri E.
    Quillin, R. Cutler
    Rana, Abbas
    Agopian, Vatche G.
    Lee-Riddle, Grace S.
    Markovic, Daniela
    Paterno, Flavio
    Griesemer, Adam D.
    Amin, Arpit
    Alonso, Diane
    Rocca, Juan P.
    Borja-Cacho, Daniel
    Hernandez-Alejandro, Roberto
    Fung, John J.
    Pelletier, Shawn J.
    Shah, Shimul A.
    Guarrera, James V.
    HEPATOLOGY, 2024, 79 (05) : 1033 - 1047
  • [2] Ultrasononography in Managing Extrapulmonary Tuberculosis: A Randomized, Controlled, Parallel, Superiority, Open-Label Trial
    Ndege, Robert
    Ngome, Omary
    Vanobberghen, Fiona
    Bani, Farida
    Temba, Yvan
    Wilson, Herieth
    Hella, Jerry
    Gingo, Winfrid
    Sasamalo, Mohamed
    Mnzava, Dorcas
    Kimera, Namvua
    Hiza, Hellen
    Wigayi, John
    Mapesi, Herry
    Kato, Irene B.
    Mhimbira, Francis
    Reither, Klaus
    Battegay, Manuel
    Paris, Daniel H.
    Weisser, Maja
    Rohacek, Martin
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (06) : 1013 - 1021
  • [3] Almond oil for patients with hyperlipidemia: A randomized open-label controlled clinical trial
    Zibaeenezhad, Mohammad Javad
    Ostovan, Parham
    Mosavat, Seyed Hamdollah
    Zamirian, Mahmood
    Attar, Armin
    COMPLEMENTARY THERAPIES IN MEDICINE, 2019, 42 : 33 - 36
  • [4] Impact of routine spirometry on clinical decisions and quality of life in children: an open-label randomised controlled trial
    Boonjindasup, W.
    Marchant, J.
    Mcelrea, M.
    Yerkovich, S.
    Masters, I.
    Chang, A.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [5] An open-label clinical trial of nefazodone in hypochondriasis
    Kjernisted, KD
    Enns, MW
    Lander, M
    PSYCHOSOMATICS, 2002, 43 (04) : 290 - 294
  • [6] Xyloglucan for the treatment of acute diarrhea: results of a randomized, controlled, open-label, parallel group, multicentre, national clinical trial
    Gnessi, Lucio
    Bacarea, Vladimir
    Marusteri, Marius
    Pique, Nuria
    BMC GASTROENTEROLOGY, 2015, 15
  • [7] Restrictive or liberal transfusion for cardiac surgery: Spanish results of a randomized multicenter international parallel open-label clinical trial
    Galan, J.
    Mateo, E.
    Carmona, P.
    Gajate, L.
    Mazer, C. D.
    Martinez-Zapata, M. J.
    MEDICINA INTENSIVA, 2022, 46 (01) : 53 - 57
  • [8] Xyloglucan for the treatment of acute diarrhea: results of a randomized, controlled, open-label, parallel group, multicentre, national clinical trial
    Lucio Gnessi
    Vladimir Bacarea
    Marius Marusteri
    Núria Piqué
    BMC Gastroenterology, 15
  • [9] Randomized open-label trial of dextromethorphan in Rett syndrome
    Smith-Hicks, Constance L.
    Gupta, Siddharth
    Ewen, Joshua B.
    Hong, Manisha
    Kratz, Lisa
    Kelley, Richard
    Tierney, Elaine
    Vaurio, Rebecca
    Bibat, Genila
    Sanyal, Abanti
    Yenokyan, Gayane
    Brereton, Nga
    Johnston, Michael V.
    Naidu, Sakkubai
    NEUROLOGY, 2017, 89 (16) : 1684 - 1690
  • [10] A randomized open-label clinical trial on the effect of Amantadine on post Covid 19 fatigue
    Harandi, Ali Amini
    Pakdaman, Hossein
    Medghalchi, Aida
    Kimia, Negin
    Kazemian, Alireza
    Siavoshi, Fatemeh
    Barough, Siavash Shirzadeh
    Esfandani, Akram
    Hosseini, Mohammad Hossein
    Sobhanian, Seyed Ali
    SCIENTIFIC REPORTS, 2024, 14 (01)